BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 23843353)

  • 1. Barth syndrome.
    Jefferies JL
    Am J Med Genet C Semin Med Genet; 2013 Aug; 163C(3):198-205. PubMed ID: 23843353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrafamilial variability for novel TAZ gene mutation: Barth syndrome with dilated cardiomyopathy and heart failure in an infant and left ventricular noncompaction in his great-uncle.
    Ronvelia D; Greenwood J; Platt J; Hakim S; Zaragoza MV
    Mol Genet Metab; 2012 Nov; 107(3):428-32. PubMed ID: 23031367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barth syndrome.
    Clarke SL; Bowron A; Gonzalez IL; Groves SJ; Newbury-Ecob R; Clayton N; Martin RP; Tsai-Goodman B; Garratt V; Ashworth M; Bowen VM; McCurdy KR; Damin MK; Spencer CT; Toth MJ; Kelley RI; Steward CG
    Orphanet J Rare Dis; 2013 Feb; 8():23. PubMed ID: 23398819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barth Syndrome Cardiomyopathy: An Update.
    Pang J; Bao Y; Mitchell-Silbaugh K; Veevers J; Fang X
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide.
    Sabbah HN
    Heart Fail Rev; 2021 Mar; 26(2):237-253. PubMed ID: 33001359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barth syndrome-related cardiomyopathy is associated with a reduction in myocardial glucose oxidation.
    Greenwell AA; Gopal K; Altamimi TR; Saed CT; Wang F; Tabatabaei Dakhili SA; Ho KL; Zhang L; Eaton F; Kruger J; Al Batran R; Lopaschuk GD; Oudit GY; Ussher JR
    Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2255-H2269. PubMed ID: 33929899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of TAZ mutations in pediatric patients with cardiomyopathy by targeted next-generation sequencing in a Chinese cohort.
    Wang J; Guo Y; Huang M; Zhang Z; Zhu J; Liu T; Shi L; Li F; Huang H; Fu L
    Orphanet J Rare Dis; 2017 Feb; 12(1):26. PubMed ID: 28183324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiolipin Remodeling Defects Impair Mitochondrial Architecture and Function in a Murine Model of Barth Syndrome Cardiomyopathy.
    Zhu S; Chen Z; Zhu M; Shen Y; Leon LJ; Chi L; Spinozzi S; Tan C; Gu Y; Nguyen A; Zhou Y; Feng W; Vaz FM; Wang X; Gustafsson AB; Evans SM; Kunfu O; Fang X
    Circ Heart Fail; 2021 Jun; 14(6):e008289. PubMed ID: 34129362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the understanding of Barth syndrome.
    Aprikyan AA; Khuchua Z
    Br J Haematol; 2013 May; 161(3):330-8. PubMed ID: 23432031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eponym: Barth syndrome.
    Takeda A; Sudo A; Yamada M; Yamazawa H; Izumi G; Nishino I; Ariga T
    Eur J Pediatr; 2011 Nov; 170(11):1365-7. PubMed ID: 21947198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted overexpression of catalase to mitochondria does not prevent cardioskeletal myopathy in Barth syndrome.
    Johnson JM; Ferrara PJ; Verkerke ARP; Coleman CB; Wentzler EJ; Neufer PD; Kew KA; de Castro BrĂ¡s LE; Funai K
    J Mol Cell Cardiol; 2018 Aug; 121():94-102. PubMed ID: 30008435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased mtDNA Abundance and Improved Function in Human Barth Syndrome Patient Fibroblasts Following AAV-
    Suzuki-Hatano S; Sriramvenugopal M; Ramanathan M; Soustek M; Byrne BJ; Cade WT; Kang PB; Pacak CA
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipid abnormalities in children with Barth syndrome.
    Schlame M; Kelley RI; Feigenbaum A; Towbin JA; Heerdt PM; Schieble T; Wanders RJ; DiMauro S; Blanck TJ
    J Am Coll Cardiol; 2003 Dec; 42(11):1994-9. PubMed ID: 14662265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of infantile Barth syndrome with severe heart failure: Importance of splicing variants in the TAZ gene.
    Takeda A; Ueki M; Abe J; Maeta K; Horiguchi T; Yamazawa H; Izumi G; Chida-Nagai A; Sasaki D; Tsujioka T; Sato I; Shiraishi M; Matsuo M
    Mol Genet Genomic Med; 2023 Jul; 11(7):e2190. PubMed ID: 37186429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barth syndrome in a female patient.
    Cosson L; Toutain A; Simard G; Kulik W; Matyas G; Guichet A; Blasco H; Maakaroun-Vermesse Z; Vaillant MC; Le Caignec C; Chantepie A; Labarthe F
    Mol Genet Metab; 2012 May; 106(1):115-20. PubMed ID: 22410210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barth syndrome without tetralinoleoyl cardiolipin deficiency: a possible ameliorated phenotype.
    Bowron A; Honeychurch J; Williams M; Tsai-Goodman B; Clayton N; Jones L; Shortland GJ; Qureshi SA; Heales SJ; Steward CG
    J Inherit Metab Dis; 2015 Mar; 38(2):279-86. PubMed ID: 25112388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets.
    Zegallai HM; Hatch GM
    Mol Cell Biochem; 2021 Mar; 476(3):1605-1629. PubMed ID: 33415565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypogammaglobulinaemia and B cell lymphopaenia in Barth syndrome.
    Kudlaty E; Agnihotri N; Khojah A
    BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35732368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of Barth syndrome: a national cohort study of 22 patients.
    Rigaud C; Lebre AS; Touraine R; Beaupain B; Ottolenghi C; Chabli A; Ansquer H; Ozsahin H; Di Filippo S; De Lonlay P; Borm B; Rivier F; Vaillant MC; Mathieu-Dramard M; Goldenberg A; Viot G; Charron P; Rio M; Bonnet D; Donadieu J
    Orphanet J Rare Dis; 2013 May; 8():70. PubMed ID: 23656970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation in the G4.5 (TAZ) gene in a Greek patient with Barth syndrome.
    Bachou T; Giannakopoulos A; Trapali C; Vazeou A; Kattamis A
    Blood Cells Mol Dis; 2009; 42(3):262-4. PubMed ID: 19261493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.